Patel Chem Specialities

Patel Chem Specialities

101.50
+2.17
(2.18%)
Market Cap
247.00 Cr
EPS
6.10
PE Ratio
23.88
Dividend Yield
0.00 %
Industry
-
52 Week High
120.89
52 Week Low
85.00
PB Ratio
2.68
Debt to Equity
0.55
Sector
-
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Patel Chem Specialities Limited executed an Independent Turnkey Project Service Agreement with J & H Pharma Consultants for their Indrad Plant, valued at Rs 45 crores. The consultant will design, engineer, procure, construct, and test the project before delivering it in fully operational condition to Patel Chem Specialities. The project is located at Mouje Village, Taluka Talod. J & H Pharma Consultants is not related to the promoter or promoter group of the company, and the transaction does not fall under related party transactions.
positive
Patel Chem Specialities Limited has obtained Environmental Clearance from the Ministry of Environment, Forest and Climate Change for its proposed pharmaceutical manufacturing project at the INDRAD Plant in Gujarat. The project involves manufacturing pharmaceutical APIs and bulk drugs including sodium starch glycolate, croscarmellose sodium, and microcrystalline cellulose with a total capacity of 501 MT/month. The facility is located at New Survey No. 405, Village Indrad, Tal Kadi, Dist Mehsana, Gujarat. The project has an estimated cost of Rs 19.75 crore with Rs 2.41 crore allocated for environmental pollution control measures and Rs 2.04 crore annual recurring costs. The company will employ 25 people directly and indirectly, and has allocated Rs 40 lakhs for Corporate Environmental Responsibility activities. The clearance is perpetual and enables the company to commence business activities at the plant.
Forecast
Actual
Growth Rate
Revenue Growth
27.69 %
Net Income Growth
37.66 %
Cash Flow Change
-68.75 %
ROE
-23.87 %
ROCE
-19.05 %
EBITDA Margin (Avg.)
2.55 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
43
61
70
83
106
0
Expenses
40
56
64
71
90
0
EBITDA
3
5
6
12
16
0
Operating Profit %
6 %
7 %
8 %
14 %
15 %
0 %
Depreciation
0
0
1
1
1
0
Interest
0
1
1
1
1
0
Profit Before Tax
2
4
4
10
14
0
Tax
0
1
1
3
4
0
Net Profit
1
2
3
8
11
0
EPS in ₹
13.20
1.34
1.70
4.50
6.10
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
18
24
37
47
65
Fixed Assets
6
10
14
14
14
Current Assets
11
13
23
27
39
Capital Work in Progress
0
0
0
3
12
Investments
0
0
0
0
0
Other Assets
13
13
24
31
39
Total Liabilities
18
24
37
47
65
Current Liabilities
9
11
19
20
22
Non Current Liabilities
3
4
6
7
8
Total Equity
7
9
12
20
35
Reserve & Surplus
6
8
11
19
18
Share Capital
1
1
1
1
18

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-1,670
-1
-1
1
0
Investing Activities
-1,978
-4
-3
-6
-7
Operating Activities
-24
2
2
6
2
Financing Activities
332
0
1
0
5

Share Holding

% Holding
Dec 2024
Jun 2025
Jul 2025
Promoter
95.13 %
68.36 %
68.36 %
FIIs
0.00 %
6.50 %
6.50 %
DIIs
0.00 %
6.83 %
6.83 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
16.74 %
16.74 %
Others
4.87 %
1.58 %
1.58 %
No of Share Holders
92
1,084
92

Technical Indicators

RSI(14)
Neutral
46.39
ATR(14)
Volatile
5.50
STOCH(9,6)
Neutral
20.37
STOCH RSI(14)
Oversold
15.64
MACD(12,26)
Bearish
-0.98
ADX(14)
Strong Trend
27.98
UO(9)
Bearish
40.11
ROC(12)
Downtrend And Accelerating
-4.29
WillR(14)
Neutral
-74.63

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
WhiteOak Capital Equity Savings Fund Direct - Growth
0.00%
-70400
-0.52%
0.00%